“…44,48,58 In contrast, benefiting from their capacity for co-delivery and targeting owing to their unique lipid bilayers, amphiphilic polymer micelles 180 and liposomes 181 incorporating CHMs are more extensively used in anti-tumor therapy. 3,85,94,101 CDs and nanofibers based on CHMs have strong anti-inflammatory effects and promote wound healing. 35,106,167 Therefore, because CHMs have a lower toxicity and a stronger synergistic effect than many synthetic drugs and, furthermore, operate under the premise of ''multi-component, multi-target'', oral formulations of CHMs can form the basis of a prospective method for new drug development.…”